The Year Ahead for FSP: Open Source, AI, Global Reach, and Cost Efficiency


February 25, 2025

The Biometrics FSP outsourcing market is evolving faster than ever. Looking back, 2024 was a year of transition for our industry as we put the COVID bubble in our rearview mirror and focused on efficient delivery of our portfolios. Looking ahead now to 2025, Biometrics FSP is on track for continued growth, with a strong emphasis on open-source technologies, global reach, artificial intelligence, and cost efficiency.

Here, I touch a bit on these four areas and share our thoughts on the impact they will have in 2025 and beyond.

 

Embracing open-source technologies

While the adoption of open-source programming has been slower in the clinical research space, tools like R and Shiny are quickly gaining traction as cost-effective and reliable solutions for data analysis and submissions.

Cytel has been leveraging open-source software for big data aggregation, application development, and validation. We will continue to be a key contributor to the open-source ecosystem and help organizations solve key design and analysis challenges, while offering access to the industry’s top R/Shiny talent pool.

 

Offshoring hub strategy and cost-effective solutions

The demand for more cost-effective solutions continues to drive the use of offshore resources across the industry. Cytel’s expansion into Eastern Europe and continued growth of our South Africa– and India-based teams positions us well to support our sponsors in reducing costs while maintaining the high levels of quality they have come to expect of Cytel.

 

Artificial intelligence

AI is revolutionizing the biometrics space by enabling real-time data monitoring, automated code generation, and improving statistical accuracy in clinical trials. By flagging anomalies and potential errors, AI reduces the risk of data discrepancies and enhances overall data quality. AI-powered tools are streamlining biometric services, automating routine tasks and allowing researchers to focus on high-value activities.

 

Secure data collection and real-time monitoring

Innovations in data collection and real-time monitoring are improving privacy, security, and data integrity. Advanced authentication methods and AI integration are helping ensure the accuracy and confidentiality of data.

Automation is also playing a key role by extracting data from unstructured sources, such as medical records, and reducing human error during data transcription. This further enhances the efficiency of electronic data capture (EDC) systems and boosts the overall reliability of clinical data.

 

Final takeaways

I’m more excited about 2025 than any year in my career. In an industry that has been criticized for moving too slowly and cautiously, we sit an inflection point for rapid evolution of decades-old models. Change can be exciting and scary all the same. Reach out — myself and our FSP experts are eager to present content and engage with you throughout the year at events such as PHUSE, JSM, SCDM, and more.

Contact Us
Subscribe to our newsletter
Corey Dunham

Corey Dunham

Senior Vice President, FSP

Corey has more than 20 years of experience working within CROs. He is an industry-recognized expert in clinical trial design and implementation, as well as an authority on innovative approaches to data management and technologies such as EDC, ePRO, CTMS, and IXRS.

Under Corey’s leadership​,​ Cytel has expanded the offerings of the traditional Functional Service Provider model, leaning into the company’s history and expertise as a strategic partner in analytics and advanced and responsive trial designs. Now known as Analytics on Demand, Corey and his team continue to evolve the role of bespoke expertise in service provision.

Prior to joining Cytel, Corey worked as a Vice President at ICON in multiple roles from Operations to Commercial. Most recently, he was responsible for the commercial development and direction of the Functional Solutions business and its solutions in the global FSP market. Corey also employed his strategic planning and leadership as VP of Operations and Head of Americas for the DOCS Global division, where he led over 2,000 staff in the key areas of Functional Services, Strategic Resourcing, and Capacity Management.

Corey holds a Bachelor of Science in Biology from the University of Maryland, College Park, and studied Executive Leadership at the Michael Smurfit Graduate Business School at the University College of Dublin.

Read full employee bio

Claim your free 30-minute strategy session

Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug’s probability of success and plot a clearer route to market.

glow-ring
glow-ring-second